The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with AZD 1775 (MK 1775) in women with recurrent, platinum-resistant epithelial ovarian, primary peritoneal, or Fallopian tube cancers: Trial of Princess Margaret, Mayo, Chicago, and California consortia.
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca
 
Johanne Ingrid Weberpals
Consulting or Advisory Role - AstraZeneca
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris
 
Alexander Olawaiye
No Relationships to Disclose
 
Irene Brana
No Relationships to Disclose
 
Helen Mackay
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Michelle K. Wilson
Consulting or Advisory Role - AstraZeneca
 
Victor Rodriguez-Freixinos
No Relationships to Disclose
 
Cristina Martin-Lorente
No Relationships to Disclose
 
Jacklyn Ward
No Relationships to Disclose
 
Karen Chang
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Vanessa Speers
No Relationships to Disclose
 
Katherine Karakasis
No Relationships to Disclose
 
Valerie Lydia Bowering
Consulting or Advisory Role - AstraZeneca
 
Alice Chen
No Relationships to Disclose
 
James Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Clovis Oncology
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche